377
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Effects of Surgical Intervention for Bone Metastases on Survival in Patients with Advanced Cancer: A Nationwide Population-Based Cohort Study

, , , , , , & ORCID Icon show all
Pages 1661-1671 | Published online: 03 May 2021

References

  • Bauer HC. Controversies in the surgical management of skeletal metastases. J Bone Joint Surg Br. 2005;87(5):608–617. doi:10.1302/0301-620X.87B5.16021
  • Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
  • Ratasvuori M, Wedin R, Hansen BH, et al. Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases. J Surg Oncol. 2014;110(4):360–365. doi:10.1002/jso.23654
  • Hansen BH, Keller J, Laitinen M, et al. The Scandinavian Sarcoma Group skeletal metastasis register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand. 2004;75(Suppl 311):11–15. doi:10.1080/00016470410001708270
  • Camnasio F, Scotti C, Peretti GM, Fontana F, Fraschini G. Prosthetic joint replacement for long bone metastases: analysis of 154 cases. Arch Orthop Trauma Surg. 2008;128(8):787–793. doi:10.1007/s00402-007-0464-y
  • Sarahrudi K, Greitbauer M, Platzer P, Hausmann JT, Heinz T, Vécsei V. Surgical treatment of metastatic fractures of the femur: a retrospective analysis of 142 patients. J Trauma. Acute Care Surg. 2009;66(4):1158–1163. doi:10.1097/TA.0b013e3181622bca
  • Lee CK, Davies L, Wu YL, et al. Gefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survival. J Natl Cancer Inst. 2017;109(6). doi:10.1093/jnci/djw279.
  • Swain SM, Clark E, Baselga J. Treatment of HER2-positive metastatic breast cancer. N Engl J Med. 2015;372(20):1964–1965. doi:10.1056/NEJMoa1413513
  • Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643–648. doi:10.1016/S0140-6736(05)66954-1
  • Feiz-Erfan I, Rhines LD, Weinberg JS. The role of surgery in the management of metastatic spinal tumors. Semin Oncol. 2008;35(2):108–117. doi:10.1053/j.seminoncol.2007.12.005
  • Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine (Phila Pa 1976). 2001;26(3):298–306. doi:10.1097/00007632-200102010-00016
  • Kakhki VR, Anvari K, Sadeghi R, Mahmoudian AS, Torabian-Kakhki M. Pattern and distribution of bone metastases in common malignant tumors. Nucl Med Rev Cent East Eur. 2013;16(2):66–69. doi:10.5603/NMR.2013.0037
  • Krishnan CK, Han I, Kim HS. Outcome after surgery for metastases to the pelvic bone: a single institutional experience. Clin Orthop Surg. 2017;9(1):116–125. doi:10.4055/cios.2017.9.1.116
  • Talbot M, Turcotte RE, Isler M, Normandin D, Iannuzzi D, Downer P. Function and health status in surgically treated bone metastases. Clin Orthop Relat Res. 2005;438:215–220. doi:10.1097/01.blo.0000170721.07088.2e
  • Wedin R, Hansen BH, Laitinen M, et al. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus. J Shoulder Elbow Surg. 2012;21(8):1049–1055. doi:10.1016/j.jse.2011.06.019
  • Johnson SK, Knobf MT. Surgical interventions for cancer patients with impending or actual pathologic fractures. Orthop Nurs. 2008;27(3):160–171. doi:10.1097/01.NOR.0000320543.90115.d5
  • Vadhan-Raj S, von Moos R, Fallowfield LJ, et al. Clinical benefit in patients with metastatic bone disease: results of a Phase 3 study of denosumab versus zoledronic acid. Ann Oncol. 2012;23(12):3045–3051. doi:10.1093/annonc/mds175
  • Scagliotti GV, Hirsh V, Siena S, et al. Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol. 2012;7(12):1823–1829. doi:10.1097/JTO.0b013e31826aec2b
  • Stopeck AT, Lipton A, Body JJ, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol. 2010;28(35):5132–5139. doi:10.1200/JCO.2010.29.7101
  • Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005;23(34):8580–8587. doi:10.1200/JCO.2005.02.8670
  • Lu JR, Chiang TL. Developing an adequate supply of health services: taiwan’s path to universal health coverage. Soc Sci Med. 2018;198:7–13. doi:10.1016/j.socscimed.2017.12.017